| Code | Description | Claims | Beneficiaries | Total Paid |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
48 |
45 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
128 |
118 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
52 |
52 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
246 |
65 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
38 |
25 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
26 |
13 |
$2K |
| 96127 |
|
115 |
91 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17 |
17 |
$1K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
90 |
69 |
$776.74 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
18 |
18 |
$526.35 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
28 |
16 |
$402.23 |
| 99000 |
|
217 |
110 |
$101.39 |